Analisis Biaya Dan Rasionalitas Terapi Paru Obstruktif Kronik Di RSU Anwar Medika Sidoarjo

Lorensia, Amelia and Jalmav, Marthy Meliana and Yorasaki, Yosy Athaya and Saputra, I Nyoman Dodi and Gitaputri, Putu Aprilya (2024) Analisis Biaya Dan Rasionalitas Terapi Paru Obstruktif Kronik Di RSU Anwar Medika Sidoarjo. Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan, 9 (1). pp. 144-159. ISSN 2502-647X; e-ISSN 2503-1902

PDF repository jiis (digabung).pdf Download (8MB)

Abstract

COPD is the main cause of death, and is currently the fifth cause of death in the world. COPD patients experience decreased capacity for quality of life, physical disability and increased costs of living. In COPD patients, the use of more than one drug therapy and long-term use can carry the risk of drug-related problems. The aim is to analyze the costs and rationality of treating COPD exacerbations. The research design was retrospective to determine the costs and description of therapy for COPD patients at RSU Anwar Medika Sidoarjo. The variables are real costs, INA-CBGs rates, severity and treatment therapy. The research sample was inpatients with BPJS insurance who were diagnosed with COPD attacks at RSU Anwar Medika Sidoarjo for January 2019-December 2021, using the total sampling method. The data collection by observing research materials including medical records. Data analysis is descriptive for data analysis and the incidence of drug-related problems (MTO), and the Mann-Whitney test to determine significant differences between real hospital costs and INA CBG'S inpatient rates. The number of respondents involved was 81 people. The highest components of direct costs incurred by COPD patients during hospitalization are hotel room costs and the cost of consumable medical materials. There was no difference in real costs compared to the rates INA-CBG's (p=0.158). The total incidence of MTO that occurred was 83 cases consisting of inappropriate drug selection (19.27%), drugs without indications (66.26%), inappropriate drug combinations (4.81%), indications without drugs (2 .40%), too many drugs for same indication (7.22%).

Item Type:	Article
Uncontrolled Keywords:	COPD, real costs, INA-CBGs rates, drug-related problems
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Faculty of Pharmacy > Department of Pharmacy
Depositing User:	Ester Sri W. 196039
Date Deposited:	22 Apr 2024 03:19
Last Modified:	22 Apr 2024 03:19
URI:	http://repository.ubaya.ac.id/id/eprint/46253

Actions (login required)

View Item